Atorvastatin-loaded cubosome: a repurposed targeted delivery systems for enhanced targeting against breast cancer

References

• Abd Eldaim MA, Tousson E, El Sayed IET, Abd El-Aleim AE-A, Elsharkawy HN. 2019. Grape seeds proanthocyanidin extract ameliorates ehrlich solid tumor induced renal tissue and DNA damage in mice. Biomed Pharmacother. 115:108908. doi: 10.1016/j.biopha.2019.108908.
   PubMed Web of Science ®Google Scholar
• Abd Elhalim SM, Ibrahim IT. 2015. Radioiodination of 2,3-dimethyl-4H-furo[3,2-c]coumarin and biological evaluation in solid tumor bearing mice. Appl Radiat Isot. 95:153–158. doi: 10.1016/j.apradiso.2014.09.011.
   PubMed Web of Science ®Google Scholar
• Abourehab MAS, Ansari MJ, Singh A, Hassan A, Abdelgawad MA, Shrivastav P, Abualsoud BM, Amaral LS, Pramanik S. 2022. Cubosomes as an emerging platform for drug delivery: a review of the state of the art. J Mater Chem B. 10(15):2781–2819. doi: 10.1039/d2tb00031h.
   PubMed Web of Science ®Google Scholar
• Aldubayan MA, Elgharabawy RM, Ahmed AS, Tousson E. 2019. Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice. Oxid Med Cell Longev. 2019:5162687. doi: 10.1155/2019/5162687.
   PubMed Web of Science ®Google Scholar
• Angelova A, Angelov B, Garamus VM, Drechsler M. 2019. A vesicle-to-sponge transition via the proliferation of membrane-linking pores in -ë-3 polyunsaturated fatty acid-containing lipid assemblies. J Mol Liq. 279:518–523. doi: 10.1016/j.molliq.2019.01.124.
   Web of Science ®Google Scholar
• Beckwitt CH, Brufsky A, Oltvai ZN, Wells A. 2018. Statin drugs to reduce breast cancer recurrence and mortality. Breast Cancer Res. 20(1):144. doi: 10.1186/s13058-018-1066-z.
   PubMedGoogle Scholar
• Buranrat B, Senggunprai L, Prawan A, Kukongviriyapan V. 2016. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells. Life Sci. 153:41–49. doi: 10.1016/j.lfs.2016.04.018.
   PubMed Web of Science ®Google Scholar
• El-Gendy MA, Mansour M, El-Assal MIA, Ishak RAH, Mortada ND. 2023. Travoprost liquid nanocrystals: an innovative armamentarium for effective glaucoma therapy. Pharmaceutics. 15(3):954.
   PubMed Web of Science ®Google Scholar
• El-Tawoosy M, Farouk N, El-Bayoumy AS. 2011. Labeling of atenolol with radioactive iodine-125 using N-bromosuccinimide and hydrogen peroxide as oxidizing agents. J Radioanal Nucl Chem. 290(3):595–600. doi: 10.1007/s10967-011-1303-8.
   Web of Science ®Google Scholar
• Elfaky M, Sirwi A, Tolba H, Shaik R, Selmi N, Alattas A, Albreki R, Alshreef N, Gad H. 2021. Development, optimization, and antifungal assessment of ocular gel loaded with ketoconazole cubic liquid crystalline nanoparticles. J Pharm Sci. 110(5):2210–2220. doi: 10.1016/j.xphs.2021.02.022.
   PubMed Web of Science ®Google Scholar
• Fayez H, El-Motaleb MA, Selim AA. 2020. Synergistic cytotoxicity of shikonin-silver nanoparticles as an opportunity for lung cancer. J Labelled Comp Radiopharm. 63(1):25–32. doi: 10.1002/jlcr.3818.
   PubMed Web of Science ®Google Scholar
• Fromigué O, Hamidouche Z, Marie PJ. 2008. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem. 283(45):30549–30556. doi: 10.1074/jbc.M801436200.
   PubMed Web of Science ®Google Scholar
• Gambhire VM, Salunkhe SM, Gambhire MS. 2018. Atorvastatin-loaded lipid nanoparticles: antitumor activity studies on MCF-7 breast cancer cells. Drug Dev Ind Pharm. 44(10):1685–1692. doi: 10.1080/03639045.2018.1492605.
   PubMed Web of Science ®Google Scholar
• Halder KK, Mandal B, Debnath MC, Bera H, Ghosh LK, Gupta BK. 2008. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. J Drug Target. 16(4):311–320. doi: 10.1080/10611860801899300.
   PubMed Web of Science ®Google Scholar
• Hindler K, Cleeland CS, Rivera E, Collard CD. 2006. The role of statins in cancer therapy. Oncologist. 11(3):306–315. doi: 10.1634/theoncologist.11-3-306.
   PubMed Web of Science ®Google Scholar
• Izadeh-Tabrizi N, Malekinejad H, Varasteh S, Cheraghi H. 2017. Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4. Environ Toxicol Pharmacol. 49:8–13. doi: 10.1016/j.etap.2016.11.011.
   PubMed Web of Science ®Google Scholar
• Kabel AM, Bdel-Rahman MN, El-Sisi AE-D, Haleem MS, Ezzat NM, El Rashidy MA. 2013. Effect of atorvastatin and methotrexate on solid Ehrlich tumor. Eur J Pharmacol. 713(1–3):47–53. doi: 10.1016/j.ejphar.2013.04.049.
   PubMed Web of Science ®Google Scholar
• Karami Z, Hamidi M. 2016. Cubosomes: remarkable drug delivery potential. Drug Discov Today. 21(5):789–801. doi: 10.1016/j.drudis.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Lao SB, Zhang ZX, Xu HH, Jiang GB. 2010. Novel amphiphilic chitosan derivatives: synthesis, characterization and micellar solubilization of rotenone. Carbohydr Polym. 82(4):1136–1142. doi: 10.1016/j.carbpol.2010.06.044.
   Web of Science ®Google Scholar
• Mansour M, Abo T, Ezz T, Fathy N, Abouelfadl D, Gad H. 2020. Delineating the usage of dexamethasone-loaded cubosomes as a therapeutic armamentarium for hearing loss versus its protective effect: in vitro and in vivo animal study. J Drug Delivery Sci Technol. 61:102244. doi: 10.1016/j.jddst.2020.102244.
   Web of Science ®Google Scholar
• Mansour M, Kamel AO, Mansour S, Mortada ND. 2017. Novel polyglycerol-dioleate based cubosomal dispersion with tailored physical characteristics for controlled delivery of ondansetron. Colloids Surf B Biointerf. 156:44–54. doi: 10.1016/j.colsurfb.2017.04.052.
   PubMed Web of Science ®Google Scholar
• Alarcon Martinez T, Zeybek ND, Müftüoğlu S. 2018. Evaluation of the cytotoxic and autophagic effects of atorvastatin on MCF-7 breast cancer cells [3]. Balkan Med J. 35(3):256–262. doi: 10.4274/balkanmedj.2017.0604.
   PubMed Web of Science ®Google Scholar
• Miladi K, Sfar S, Fessi H, Elaissari A. 2015. Enhancement of alendronate encapsulation in chitosan nanoparticles. J Drug Delivery Sci Technol. 30:391–396. doi: 10.1016/j.jddst.2015.04.007.
   Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65(1–2):55–63. doi: 10.1016/0022-1759(83)90303-4.
   PubMed Web of Science ®Google Scholar
• Motaleb HA, Ibrahim IT, El-Tawoosy M, Mohamed MI. 2017. Synthesis, preclinical, and pharmacokinetic evaluation of a new zoledronate derivative as a promising antiosteoporotic candidate using radiolabeling technique. J Labelled Comp Radiopharm. 60(11):542–549. doi: 10.1002/jlcr.3532.
   PubMed Web of Science ®Google Scholar
• Mushtaq S, Jeon J, Shaheen A, Jang BS, Park SH. 2016. Critical analysis of radioiodination techniques for micro and macro organic molecules. J Radioanal Nucl Chem. 309(2):859–889.
   Web of Science ®Google Scholar
• Nasr M, Ghorab MK, Abdelazem A. 2015. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B. 5(1):79–88. doi: 10.1016/j.apsb.2014.12.001.
   PubMed Web of Science ®Google Scholar
• Nie S. 2010. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond). 5(4):523–528. doi: 10.2217/nnm.10.23.
   PubMed Web of Science ®Google Scholar
• Park SN, Jo NR, Jeon SH. 2014. Chitosan-coated liposomes for enhanced skin permeation of resveratrol. J Ind Eng Chem. 20(4):1481–1485. doi: 10.1016/j.jiec.2013.07.035.
   Web of Science ®Google Scholar
• Pink DL, Loruthai O, Ziolek RM, Terry AE, Barlow DJ, Lawrence MJ, Lorenz CD. 2021. Interplay of lipid and surfactant: impact on nanoparticle structure. J Colloid Interface Sci. 597:278–288. doi: 10.1016/j.jcis.2021.03.136.
   PubMed Web of Science ®Google Scholar
• Rashed HM, Ibrahim IT, Motaleb MA, El-Bary AA. 2014. Preparation of radioiodinated ritodrine as a potential agent for lung imaging. J Radioanal Nucl Chem. 300(3):1227–1233. doi: 10.1007/s10967-014-3077-2.
   Web of Science ®Google Scholar
• Rathore C, Hemrajani C, Sharma AK, Gupta PK, Jha NK, Aljabali AAA, Gupta G, Singh SK, Yang J-C, Dwivedi RP, et al. 2023. Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies. Drug Deliv Transl Res. 13(1):292–307. doi: 10.1007/s13346-022-01193-8.
   PubMed Web of Science ®Google Scholar
• Riyadh S, Gomha S, Mahmmoud E, Elaasser M. 2015. ChemInform abstract: synthesis and anticancer activities of thiazoles, 1,3-thiazines, and thiazolidine using chitosan-grafted-poly(vinylpyridine) as basic catalyst. Heterocycles. 91:1227.
   Web of Science ®Google Scholar
• Sabt A, Eldehna W, Al-Warhi T, Alotaibi O, Elaasser M, Suliman H, Bdel-Aziz H. 2020. Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights. J Enzyme Inhib Med Chem. 35(1):1616–1630. doi: 10.1080/14756366.2020.1806259.
   PubMed Web of Science ®Google Scholar
• Saddar E, El-Tawoosy M, Motaleb HA. 2014. Preparation and biological evaluation of radioiodinated risperidone and lamotrigine as models for brain imaging agents. J Radioanal Nucl Chem. 301(1):189–196. doi: 10.1007/s10967-014-3139-5.
   Web of Science ®Google Scholar
• Sánchez CA, Rodríguez E, Varela E, Zapata E, Páez A, Massó FA, Montaño LF, Lóopez-Marure R. 2008. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer Invest. 26(7):698–707. doi: 10.1080/07357900701874658.
   PubMed Web of Science ®Google Scholar
• Sebaaly C, Haydar S, Greige-Gerges H. 2022. Eugenol encapsulation into conventional liposomes and chitosan-coated liposomes: a comparative study. J Drug Delivery Sci Technol. 67:102942. doi: 10.1016/j.jddst.2021.102942.
   Web of Science ®Google Scholar
• Selim AA, Motaleb MA, Fayez HA. 2022. Lung cancer-targeted [131I]-iodoshikonin as theranostic agent: radiolabeling, in vivo pharmacokinetics and biodistribution. Pharm Chem J. 55(11):1163–1168. doi: 10.1007/s11094-022-02553-x.
   Web of Science ®Google Scholar
• Siafaka PI, Titopoulou A, Koukaras EN, Kostoglou M, Koutris E, Karavas E, Bikiaris DN. 2015. Chitosan derivatives as effective nanocarriers for ocular release of timolol drug. Int J Pharm. 495(1):249–264. doi: 10.1016/j.ijpharm.2015.08.100.
   PubMed Web of Science ®Google Scholar
• Tai K, Rappolt M, Mao L, Gao Y, Li X, Yuan F. 2020. The stabilization and release performances of curcumin-loaded liposomes coated by high and low molecular weight chitosan. Food Hydrocolloids. 99:105355. doi: 10.1016/j.foodhyd.2019.105355.
   Web of Science ®Google Scholar
• Tang J, Wang Y, Wang D, Wang Y, Xu Z, Racette K, Liu F. 2013. Key structure of brij for overcoming multidrug resistance in cancer. Biomacromolecules. 14(2):424–430. doi: 10.1021/bm301661w.
   PubMed Web of Science ®Google Scholar
• Tavares Luiz M, Ello Di Filippo L, Carolina Alves R, Sousa Ara Jo VH, Lobato Duarte J, Maldonado Marchetti J, Chorilli M. +¦ 2021. The use of TPGS in drug delivery systems to overcome biological barriers. Eur Polym J. 142:110129. doi: 10.1016/j.eurpolymj.2020.110129.
   Web of Science ®Google Scholar
• Tian Y, Li J, Zhu J, Zhu N, Zhang H, Liang L, Sun L. 2017. Folic acid-targeted etoposide cubosomes for theranostic application of cancer cell imaging and therapy. Med Sci Monit. 23:2426–2435. doi: 10.12659/msm.904683.
   PubMed Web of Science ®Google Scholar
• Tolmachev V, Bruskin A, Sivaev I, Lundqvist H, Sj+¦berg S. 2002. Radiobromination of closo-dodecaborate anion. Aspects Label Chem Aqueous Solution Using Chloramine-T. 90(4):229–235.
   Google Scholar
• Tulbah AS, Gamal A. 2021. Design and characterization of atorvastatin dry powder formulation as a potential lung cancer treatment. Saudi Pharm J. 29(12):1449–1457. doi: 10.1016/j.jsps.2021.11.002.
   PubMed Web of Science ®Google Scholar
• Valipour E, Ranjbar FE, Mousavi M, Ai J, Malekshahi ZV, Mokhberian N, Taghdiri-Nooshabadi Z, Khanmohammadi M, Nooshabadi VT. 2022. The anti-angiogenic effect of atorvastatin loaded exosomes on glioblastoma tumor cells: an in vitro 3D culture model. Microvasc Res. 143:104385. doi: 10.1016/j.mvr.2022.104385.
   PubMedGoogle Scholar
• Wilke M, Göbel A, Rauner M, Benad-Mehner P, Schütze N, Füssel S, Hadji P, Hofbauer LC, Rachner TD. 2014. Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells. J Bone Oncol. 3(1):10–17. doi: 10.1016/j.jbo.2014.02.001.
   PubMed Web of Science ®Google Scholar
• Xu X-T, Chen J, Ren X, Ma Y-R, Wang X, Ma Y-Y, Zhao D-G, Zhou R-P, Zhang K, Goodin S, et al. 2021. Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells. Eur J Pharmacol. 893:173840. doi: 10.1016/j.ejphar.2020.173840.
   PubMed Web of Science ®Google Scholar
• Yaghmur A, Mu H. 2021. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Acta Pharm Sin B. 11(4):871–885. doi: 10.1016/j.apsb.2021.02.013.
   PubMed Web of Science ®Google Scholar
• Yaghmur A, Tran BV, Moghimi SM. 2020. Non-lamellar liquid crystalline nanocarriers for thymoquinone encapsulation. 25(1):16.
   Google Scholar
• Zhang L, Li J, Tian D, Sun L, Wang X, Tian M. 2020. Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells. Cell Death Dis. 11(1):1. doi: 10.1038/s41419-019-2182-0.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. 2012. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 33(19):4889–4906. doi: 10.1016/j.biomaterials.2012.03.046.
   PubMed Web of Science ®Google Scholar